CRYOSTORAGE
ActiveSummary
CRYOSTORAGE has been active since 2008 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show negative equity (-€120,420) and a net result of -€26,383. Equity is shrinking by ~13.6% per year across the filed fiscal years. Its solvency ranks better than 5% of 16666 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).
Checked score
Score 2025
Axes · tick = 2024
Profitability21▼-5
Solvency0▼-1
Growth32=
Track record100
Bankruptcy probability, 12 months
0.1%
Very low
0%0.5%1.5%4%10%≥ 25%
No credit on open account
Liquidity short (current ratio 0.11 against 0.12 in 2024; short-term debt: 130.2% and cash: 14.6% of total assets), and equity is negative.
Credit check for your own amount and term
Open the credit simulator : see how the verdict changes with amount, term and advance.
Signals
Six signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Human health activities (NACE 86)
about 87% fewer bankruptcies
← fewer bankruptcies
more bankruptcies →
raises risk · Annual accounts: weaker financial profile
The latest annual accounts show a weaker profile in solvency, result or liquidity than companies that stay afloat.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
-30.2%
Return on assets
-6.6%
Age of the figures
15 mo
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation dateAge against the risk zone
raises risk · Negative equity
The 2025 annual accounts show negative equity and a net loss.
NBB · annual accounts 2025Equity per financial year
19202122232425
2019 to 2025 · latest year -€120,420
neutral · Latest accounts filed on time
The financial year that closed on 30-06-2025 was due by 31-01-2026 and was filed on 29-01-2026, 2 days ahead of the deadline.
NBB · 10 filingsDeviation from the deadline
2025
2 d early
2024
25 d early
2023
on the day
2022
on the day
2021
on the day
2020
34 d early
2019
1 d early
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
This company filed its last 7 accounts on average 9 days before the deadline; the sector median for financial year 2024 is 7 days before the deadline, and 36% of the sector filed late.
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 30-06-2026 and is due by 31-01-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
30-06-2026 close26-09-2026 today31-01-2027 deadline
History
Go further with this company
How much credit can you give this customer, and on what term?Credit simulator What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file How does this company compare with its sector?Sector benchmark What changed in the latest annual accounts?What changed Roughly what is this company worth?Value indication
Is this your company? See how customers and banks see it.
Investigating this company? Keep it with today's facts in a case file.
Financials · fiscal year 2025, micro schema
Equity
-€120,420▼ 28.1%
2024 · -€94,037
Total assets
€398,857▼ 0.1%
2024 · €399,455
Net result
-€26,383▼ 45.8%
2024 · -€18,095
Working capital
-€461,238▼ 6.1%
2024 · -€434,855
Trend over the years
Click a name to add, emphasise or remove a line.
Every figure with its change against the fiscal year before
favourable
unfavourable
Line20212022202320242025
Operating result-€4,700€38,894-€655-€589▲ 10.1%-€597▼ 1.4%
Net result-€21,954▼ 113%€24,975-€21,054-€18,095▲ 14.1%-€26,383▼ 45.8%
Equity-€79,863▼ 37.9%-€54,888▲ 31.3%-€75,942▼ 38.4%-€94,037▼ 23.8%-€120,420▼ 28.1%
Total assets€362,173▲ 4.3%€400,790▲ 10.7%€400,043▼ 0.2%€399,455▼ 0.1%€398,857▼ 0.1%
Debt€442,036▲ 9.1%€455,678▲ 3.1%€475,985▲ 4.5%€493,492▲ 3.7%€519,278▲ 5.2%
Working capital-€420,681▼ 5.5%-€395,706▲ 5.9%-€416,760▼ 5.3%-€434,855▼ 4.3%-€461,238▼ 6.1%
Turnover and EBIT margin not published: the abbreviated or micro schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result stays negative: a loss of €597 in 2025 against €589 in 2024; the loss grows.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €398,857
Fixed assets
€340,818 =
Current assets
€58,040 ▼ 1.0%
Key figures and ratios
Solvency
-30.2%▼
2024 · -23.5%
Current ratio
0.11▼
2024 · 0.12
Debt to equity
-4.31▲
2024 · -5.25
ROA
-6.6%▼
2024 · -4.5%
Debt ≤ 1 year
€519,278▲
2024 · €493,492
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Annual accounts
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Other operating charges640/8 | - | €122 | €132 | €141 | €144 | ▲ 2.6% |
| Gross operating margin9900 | -€4,580 | €39,015 | -€523 | -€448 | -€453 | ▼ 1.1% |
| Operating profit (loss)9901 | -€4,700 | €38,894 | -€655 | -€589 | -€597 | ▼ 1.4% |
| Financial charges65/66B | - | €13,919 | €20,399 | €17,506 | €25,786 | ▲ 47.3% |
| Recurring financial charges65 | €17,253 | €13,919 | €20,399 | €17,506 | €25,786 | ▲ 47.3% |
| Profit (loss) for the period before taxes9903 | -€21,954 | €24,975 | -€21,054 | -€18,095 | -€26,383 | ▼ 45.8% |
| Profit (loss) for the period9904 | -€21,954 | €24,975 | -€21,054 | -€18,095 | -€26,383 | ▼ 45.8% |
| Profit (loss) for the period to be appropriated9905 | -€21,954 | €24,975 | -€21,054 | -€18,095 | -€26,383 | ▼ 45.8% |
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Assets | ||||||
| Total assets20/58 | €362,173 | €400,790 | €400,043 | €399,455 | €398,857 | ▼ 0.1% |
| Fixed assets21/28 | €340,818 | €340,818 | €340,818 | €340,818 | €340,818 | = |
| Intangible fixed assets21 | €340,818 | €340,818 | €340,818 | €340,818 | €340,818 | = |
| Tangible fixed assets22/27 | - | - | €0 | €0 | €0 | - |
| Furniture and vehicles24 | - | - | €0 | €0 | €0 | - |
| Current assets29/58 | €21,355 | €59,973 | €59,226 | €58,637 | €58,040 | ▼ 1.0% |
| Amounts receivable within one year40/41 | €523 | €8,841 | €353 | €3 | €3 | = |
| Trade receivables40 | - | €8,219 | €350 | - | - | - |
| Other amounts receivable41 | - | €622 | €3 | €3 | €3 | = |
| Cash at bank and in hand54/58 | €12,717 | €51,132 | €58,872 | €58,634 | €58,037 | ▼ 1.0% |
| Equity and liabilities | ||||||
| Total equity and liabilities10/49 | €362,173 | €400,790 | €400,043 | €399,455 | €398,857 | ▼ 0.1% |
| Equity10/15 | -€79,863 | -€54,888 | -€75,942 | -€94,037 | -€120,420 | ▼ 28.1% |
| Contributions10/11 | €62,000 | €62,000 | €62,000 | €62,000 | €62,000 | = |
| Capital10 | - | €62,000 | €62,000 | €62,000 | €62,000 | = |
| Issued capital100 | - | €62,000 | €62,000 | €62,000 | €62,000 | = |
| Reserves13 | €110 | €110 | €110 | €110 | €110 | = |
| Non-distributable reserves130/1 | - | €110 | €110 | €110 | €110 | = |
| Legal reserve130 | - | €110 | €110 | €110 | €110 | = |
| Profit (loss) carried forward14 | -€141,973 | -€116,998 | -€138,052 | -€156,147 | -€182,530 | ▼ 16.9% |
| Amounts payable17/49 | €442,036 | €455,678 | €475,985 | €493,492 | €519,278 | ▲ 5.2% |
| Amounts payable within one year42/48 | €442,036 | €455,678 | €475,985 | €493,492 | €519,278 | ▲ 5.2% |
| Trade debts44 | €117 | €16 | - | - | - | - |
| Suppliers440/4 | - | €16 | - | - | - | - |
| Other amounts payable47/48 | - | €455,663 | €475,985 | €493,492 | €519,278 | ▲ 5.2% |
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Profit (loss) for the period9904 | -€21,954 | €24,975 | -€21,054 | -€18,095 | -€26,383 | ▼ 45.8% |
| Operating cash flow (approximation) | -€21,954 | €24,975 | -€21,054 | -€18,095 | -€26,383 | ▼ 45.8% |
| Investment in fixed assets (approximation) | - | €0 | €0 | €0 | €0 | - |
| Change in cash | - | €38,414 | €7,740 | -€238 | -€597 | ▼ 151% |
Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
23-09
State Gazette act
Restructuring · MiscellaneousMerger · Shareholding · Legal form clause14 facts ▸
State Gazette act
Restructuring · Miscellaneous
Merger · Shareholding · Legal form clause14 facts ▸
- Merger, met fusie door overneming gelijkgestelde verrichting, hele vermogen van [B] overgaat op [A] door ontbinding zonder vereffening
- Shareholding, 100
- Other statement, economische verantwoording
- Other statement, vereenvoudiging juridische en administratieve structuur
- Other statement, zakelijke en economische overwegingen
- Legal form clause, Cryostorage
- Declaration, no special rights or other securities
- Declaration, no special rights or other securities
- Declaration, no special advantage to board members
- Declaration, no special advantage to board members
- Declaration, no real estate or real property rights
- Statutes amendment
- +2 further facts in this act
20-03
State Gazette act
Resignations: MG Investment (director) and Robert Broothaerts (director)Reappointment: MG Investment (director) · Permanent representative: Ignace De Paepe5 facts ▸
State Gazette act
Resignations: MG Investment (director) and Robert Broothaerts (director)
Reappointment: MG Investment (director) · Permanent representative: Ignace De Paepe5 facts ▸
- Board meeting, 01/12/2022
- Director resignation, MG Investment (director)
- Director resignation, Robert Broothaerts (director)
- Director reappointment, MG Investment (director)
- Permanent representative, Ignace De Paepe
29-01
NBB filing
Annual accounts filed
fiscal year 2025 · micro schema
2025
30-06
Financial
Weakest financial yearnet -€26,383
Net result drops to -€26,383, the lowest in the series.
06-01
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema
2024
31-01
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema
2023
31-01
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema
2022
30-06
Financial
Back to profitnet €24,975
Net result €24,975 after 3 loss-making years.
31-01
NBB filing
Annual accounts filed
fiscal year 2021 · abbreviated schema
2020
28-12
NBB filing
Annual accounts filed
fiscal year 2020 · abbreviated schema
30-01
NBB filing
Annual accounts filed
fiscal year 2019 · abbreviated schema
2018
19-12
NBB filing
Annual accounts filed
fiscal year 2018 · micro schema
2017
14-12
NBB filing
Annual accounts filed
fiscal year 2017 · micro schema
01-02
NBB filing
Annual accounts filed
fiscal year 2016 · abbreviated schema · 1 day late
Financial milestoneState Gazette actNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
2 of 6 acts read
About the unread acts
Of the 6 Belgian State Gazette acts we know for this company, 2 have been read. The other 4 have not been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.
Directors · office · real estate
Directors
1 director, last change in 2026
Board 1
MG Investment
CurrentDirector · Legal entity · perm. rep.: Ignace De Paepe
Permanent representatives 1
Ignace De Paepe
CurrentPermanent representative · for MG Investment
Derived from published Gazette acts. The CBE keeps the official list of function holders; we do not read it, so the two can differ.
See the function holders in the CBE →
Not every act has been read: a resignation may be missing here
4 of this company's 6 Belgian State Gazette acts have not been read yet. Appointments and resignations recorded in them are missing above: a director who resigned there may therefore still show here as sitting. The acts are in the Timeline.
Location & real-estate footprint
Registered office, Gent · 1 establishment unit since 2008
Ground area
1,701 m²
Building footprint
822 m²
Volume, LiDAR
526 m³
Parcel 44809I0649/52A002, Flanders · tallest building 4.8 m. Linked by address, not a title deed.
96
companies at this address
See who is registered here
1 establishment unit
Esplanade Oscar Van de Voorde 1, 9000 Gent
since 20082.173.637.366
1 parcel
Flanders
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 44809I0649/52A002 | Flanders | 1,701 m² | 1 · 822 m² | 4.8 m |
Linked by address, not proof of ownership
Good to know
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Mandate history
2 people since 2026, 1 in office
- Board
- began earlier
| Name | Functions and periods |
|---|---|
| MG Investment |
|
| Broothaerts Robert |
|
Articles of association
Purpose
Het testen, bewerken, bewaren en distribueren van menselijk lichaamsmateriaal, samples en andere materialen in een stofvrije, geklimatiseerde omgeving (biobank) die voorzien is van…
Full purpose (5 activities)
- Het testen, bewerken, bewaren en distribueren van menselijk lichaamsmateriaal, samples en andere materialen in een stofvrije, geklimatiseerde omgeving (biobank) die voorzien is van een kwaliteitssysteem en uitgerust is met alle nodige en voorgeschreven veiligheden om deze unieke en waardevolle materialen vierentwintig (24) uur per dag, zeven (7) dagen in de week geeontroleerd op te slaan.
- Het aankopen, verkopen, importeren, exporteren, plaatsen, inrichten, onderhouden en herstellen van systemen, toestellen en installaties voor bewaring in een koude - en/of wanne omgeving.
- De vennootschap mag alle technisehe ontwerpactivitciten uitvoeren, bouwen en assembleren van deze systcmen, toestellen en installaties evenals het plaatsen van alle somten elektronischc installaties.
- De vennootschap mag tevens verhuring en bet onderhoud doen, zowel voor eigen rekening als voor rekening van derden, zelfs als commissionair en tussenpersoon, in de meest ruime zin.
- Dit alles in de meest ruime zin. De vennootschap handelt voor eigen rekening, in consignatie, in commissie, als tussenpersoon of als vertegenwoordiger. Zij mag deelnemen in alle ondernemingen die ene gelijkaardig voorwerp nastreven, ook aanverwant, of die de verwezenlijking van het voorwerp vergemakkelijken. In de algemene regel mag de vennootschap alle daden stellen van burgerlijke, commerciële, roerende, onroerende, industriële of financiële aard, welke rechtstreeks of onrechtstreeks, geheel of gedeeltelijk in verband staan met het voorwerp.
Other statement
One provision in the deed
Accounting effect
01-07-2026
Structure & network
Connections & network
1 current directorThe network starts from this company’s directors. Other companies they run appear here as nodes.
This company
Company
Director
Shareholding
+N: links not shown yet
Click a node to look further, drag to arrange, scroll to zoom.
Acquisitions and mergers
1 transactionTaken over by:NEVIMO NV
Capital and shareholders
Shareholders according to the acts
Stated in the act
act of 23-09-2026 ↗
- NEVIMO NV (BE 0446.588.493) all shares · 100%
The Belgian State Gazette names shareholders only when an act mentions them; the share register itself is not published.
Similar companies · same sector and region
DERMPAT
BE 0842.445.493
Gent
Dokter Fr. Cuigniez - Medische Beeldvorming
BE 0541.977.602
Gent
DOKTER WERNER ALEX FACHE
BE 0475.773.716
Gent
Eleonora Cottone-Apotheker-Klinisch bioloog
BE 1011.915.381
Gent
Geert Leroux-Roels
BE 0682.614.932
Gent
This company's figures show no positive equity and no headcount, so a size comparison is not possible. These companies share only the sector and the region. Of 699 companies in sector 86910 we hold annual accounts for 521. See the whole sector
Identification & contact
Identification
Legal formPublic limited company
Founded05-08-2008
Fiscal year end30-06
Activities, NACEBEL 2025
86910Medical imaging and medical laboratories
52100Warehousing and storage
Scores and ratios are computed by Checked and are not a credit decision.